Nordstjernan to invest in medtech company Ascilion

Nordstjernan is investing in Ascilion, a Swedish medtech company founded in 2012 and based in Stockholm, Sweden. Ascilion has developed and patented a technology that uses an array of hollow microneedles to extract the interstitial fluid (ISF) that surrounds the body’s cells and that is a good carrier of biomarkers. Ascilion’s technology has numerous fields of application, including within several branches of medical diagnostics. Nordstjernan will become the second largest owner in Ascilion and, as a partner to the company’s founder and current owners, the aim is to accelerate the company’s commercial development.

Click here to read the press release

Welcome to Amanda Åhman, our new Account Manager!

Amanda has a degree in International Sales B2B from IHM Business School. Since then, she has mainly worked in sales …

Read More →

PwC to acquire Mitopro

Suomen PwC on ostanut yritysvastuun raportointiin, varmennukseen ja konsultointiin erikoistuneen Mitopron. PwC vahvistaa näin sekä yritysvastuu- ja ESG-palveluitaan (Environmental, Social …

Read More →

CapMan Buyout exits Fortaco Group to One Equity Partners

Funds managed by CapMan Buyout have agreed to sell their holdings in Fortaco Group, the leading strategic partner to the …

Read More →

Standout Capital divests Miradore

Nordic small-cap technology investor Standout Capital and the other shareholders in Miradore Oy have signed binding agreements to sell their shares to GoTo, the all-in-one …

Read More →

Equistone acquires majority stake in Virgin Experience Days from Inflexion

Equistone Partners Europe has acquired a majority stake in Virgin Experience Days, a leading provider of experience gifts, from Inflexion …

Read More →

Spiltan Invest invests in Hyttbäcken

Hyttbäcken Invest AB tar in nytt kapital om 52 MSEK, varav 25 MSEK kommer från Spiltan Invest. Resterande andelar kommer …

Read More →
close-link
close-link